How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?
Identifieur interne : 000126 ( Main/Corpus ); précédent : 000125; suivant : 000127How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?
Auteurs : Stanley FahnSource :
- Annals of Neurology [ 0364-5134 ] ; 2008-12.
Abstract
The motor complications associated with levodopa therapy, namely, fluctuations in motor response and dyskinesias, occur in the majority of Parkinson's disease patients. These complications can impair a patient's quality of life and even cause pronounced disability. “Off” states that result in freezing of gait and falling are disabling for many patients. Dyskinesias most commonly occur at peak dose and typically alternate with the wearing‐off state. Once these problems appear, they usually persist, and the physician needs to make continual adjustments in medications to minimize these problems. Medical treatments should be attempted before treatments such as deep brain stimulation are considered because of the potential adverse effects that are associated with surgery. The timing of surgery, however, is also important because younger patients and less advanced patients tend to have a better outcome. There is thus a need for experienced and knowledgeable physicians and surgeons who are able to handle these motor complications. This review discusses available medications and surgical approaches, and their outcomes. Ann Neurol 2008;64 (suppl):S56–S64
Url:
DOI: 10.1002/ana.21453
Links to Exploration step
ISTEX:843236E84B9407C8CE3C3A556D642BEADB5DD433Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title><author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name><affiliation><mods:affiliation>Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:843236E84B9407C8CE3C3A556D642BEADB5DD433</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/ana.21453</idno><idno type="url">https://api.istex.fr/document/843236E84B9407C8CE3C3A556D642BEADB5DD433/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000126</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title><author><name sortKey="Fahn, Stanley" sort="Fahn, Stanley" uniqKey="Fahn S" first="Stanley" last="Fahn">Stanley Fahn</name><affiliation><mods:affiliation>Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Neurology</title><title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="ISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-12">2008-12</date><biblScope unit="volume">64</biblScope><biblScope unit="issue">S2</biblScope><biblScope unit="supplement">2</biblScope><biblScope unit="page" from="S56">S56</biblScope><biblScope unit="page" to="S64">S64</biblScope></imprint><idno type="ISSN">0364-5134</idno></series><idno type="istex">843236E84B9407C8CE3C3A556D642BEADB5DD433</idno><idno type="DOI">10.1002/ana.21453</idno><idno type="ArticleID">ANA21453</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0364-5134</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The motor complications associated with levodopa therapy, namely, fluctuations in motor response and dyskinesias, occur in the majority of Parkinson's disease patients. These complications can impair a patient's quality of life and even cause pronounced disability. “Off” states that result in freezing of gait and falling are disabling for many patients. Dyskinesias most commonly occur at peak dose and typically alternate with the wearing‐off state. Once these problems appear, they usually persist, and the physician needs to make continual adjustments in medications to minimize these problems. Medical treatments should be attempted before treatments such as deep brain stimulation are considered because of the potential adverse effects that are associated with surgery. The timing of surgery, however, is also important because younger patients and less advanced patients tend to have a better outcome. There is thus a need for experienced and knowledgeable physicians and surgeons who are able to handle these motor complications. This review discusses available medications and surgical approaches, and their outcomes. Ann Neurol 2008;64 (suppl):S56–S64</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Stanley Fahn MD</name><affiliations><json:string>Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY</json:string></affiliations></json:item></author><articleId><json:string>ANA21453</json:string></articleId><language><json:string>eng</json:string></language><abstract>The motor complications associated with levodopa therapy, namely, fluctuations in motor response and dyskinesias, occur in the majority of Parkinson's disease patients. These complications can impair a patient's quality of life and even cause pronounced disability. “Off” states that result in freezing of gait and falling are disabling for many patients. Dyskinesias most commonly occur at peak dose and typically alternate with the wearing‐off state. Once these problems appear, they usually persist, and the physician needs to make continual adjustments in medications to minimize these problems. Medical treatments should be attempted before treatments such as deep brain stimulation are considered because of the potential adverse effects that are associated with surgery. The timing of surgery, however, is also important because younger patients and less advanced patients tend to have a better outcome. There is thus a need for experienced and knowledgeable physicians and surgeons who are able to handle these motor complications. This review discusses available medications and surgical approaches, and their outcomes. Ann Neurol 2008;64 (suppl):S56–S64</abstract><qualityIndicators><score>7.004</score><pdfVersion>1.3</pdfVersion><pdfPageSize>594 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>0</keywordCount><abstractCharCount>1163</abstractCharCount><pdfWordCount>6421</pdfWordCount><pdfCharCount>41773</pdfCharCount><pdfPageCount>9</pdfPageCount><abstractWordCount>167</abstractWordCount></qualityIndicators><title>How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title><genre><json:string>article</json:string></genre><host><volume>64</volume><publisherId><json:string>ANA</json:string></publisherId><pages><total>9</total><last>S64</last><first>S56</first></pages><issn><json:string>0364-5134</json:string></issn><issue>S2</issue><subject><json:item><value>Clinical Issues</value></json:item></subject><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1531-8249</json:string></eissn><title>Annals of Neurology</title><doi><json:string>10.1002/(ISSN)1531-8249</json:string></doi></host><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1002/ana.21453</json:string></doi><id>843236E84B9407C8CE3C3A556D642BEADB5DD433</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/843236E84B9407C8CE3C3A556D642BEADB5DD433/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/843236E84B9407C8CE3C3A556D642BEADB5DD433/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/843236E84B9407C8CE3C3A556D642BEADB5DD433/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><availability><p>WILEY</p></availability><date>2008</date></publicationStmt><notesStmt><note type="content">*Potential conflicts of interest: This article is part of a supplement sponsored by Boehringer Ingelheim (BI). Within the past 12 months, S.F. has received consulting fees from BI, Anteres Pharm, Eisai, EMD Serono, IMPAX Pharma, Intec Pharma, Novartis, and Teva Pharmaceuticals. S.F. received an honorarium from Merz Pharma as a member of a safety monitoring committee.</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title><author><persName><forename type="first">Stanley</forename><surname>Fahn</surname></persName><roleName type="degree">MD</roleName><note type="correspondence"><p>Correspondence: Neurological Institute, 710 West 168th Street, New York, NY 10032</p></note><affiliation>Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY</affiliation></author></analytic><monogr><title level="j">Annals of Neurology</title><title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title><title level="j" type="abbrev">Ann Neurol.</title><idno type="pISSN">0364-5134</idno><idno type="eISSN">1531-8249</idno><idno type="DOI">10.1002/(ISSN)1531-8249</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-12"></date><biblScope unit="volume">64</biblScope><biblScope unit="issue">S2</biblScope><biblScope unit="supplement">2</biblScope><biblScope unit="page" from="S56">S56</biblScope><biblScope unit="page" to="S64">S64</biblScope></imprint></monogr><idno type="istex">843236E84B9407C8CE3C3A556D642BEADB5DD433</idno><idno type="DOI">10.1002/ana.21453</idno><idno type="ArticleID">ANA21453</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>The motor complications associated with levodopa therapy, namely, fluctuations in motor response and dyskinesias, occur in the majority of Parkinson's disease patients. These complications can impair a patient's quality of life and even cause pronounced disability. “Off” states that result in freezing of gait and falling are disabling for many patients. Dyskinesias most commonly occur at peak dose and typically alternate with the wearing‐off state. Once these problems appear, they usually persist, and the physician needs to make continual adjustments in medications to minimize these problems. Medical treatments should be attempted before treatments such as deep brain stimulation are considered because of the potential adverse effects that are associated with surgery. The timing of surgery, however, is also important because younger patients and less advanced patients tend to have a better outcome. There is thus a need for experienced and knowledgeable physicians and surgeons who are able to handle these motor complications. This review discusses available medications and surgical approaches, and their outcomes. Ann Neurol 2008;64 (suppl):S56–S64</p></abstract><textClass><keywords scheme="Journal Subject"><list><head>article category</head><item><term>Clinical Issues</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2008-04-07">Received</change><change when="2008-06-02">Registration</change><change when="2008-12">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/843236E84B9407C8CE3C3A556D642BEADB5DD433/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName><publisherLoc>Hoboken</publisherLoc></publisherInfo><doi registered="yes">10.1002/(ISSN)1531-8249</doi><issn type="print">0364-5134</issn><issn type="electronic">1531-8249</issn><idGroup><id type="product" value="ANA"></id></idGroup><titleGroup><title type="main" xml:lang="en" sort="ANNALS OF NEUROLOGY">Annals of Neurology</title><title type="subtitle">Official Journal of the American Neurological Association and the Child Neurology Society</title><title type="short">Ann Neurol.</title></titleGroup></publicationMeta><publicationMeta level="part" position="250"><doi origin="wiley" registered="yes">10.1002/ana.v64:2+</doi><titleGroup><title type="supplementTitle">Unresolved Issues in Parkinson's Disease</title></titleGroup><numberingGroup><numbering type="journalVolume" number="64">64</numbering><numbering type="journalIssue">S2</numbering><numbering type="supplement" number="2">2</numbering></numberingGroup><coverDate startDate="2008-12">December 2008</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="60" status="forIssue"><doi origin="wiley" registered="yes">10.1002/ana.21453</doi><idGroup><id type="unit" value="ANA21453"></id></idGroup><countGroup><count type="pageTotal" number="9"></count></countGroup><titleGroup><title type="articleCategory">Clinical Issues</title><title type="tocHeading1">Clinical Issues</title></titleGroup><copyright ownership="thirdParty">Copyright © 2008 American Neurological Association</copyright><eventGroup><event type="manuscriptReceived" date="2008-04-07"></event><event type="manuscriptRevised" date="2008-05-27"></event><event type="manuscriptAccepted" date="2008-06-02"></event><event type="firstOnline" date="2009-01-06"></event><event type="publishedOnlineFinalForm" date="2009-01-06"></event><event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.1 mode:FullText source:FullText result:FullText" date="2010-02-23"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-03"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst">S56</numbering><numbering type="pageLast">S64</numbering></numberingGroup><correspondenceTo>Neurological Institute, 710 West 168th Street, New York, NY 10032</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:ANA.ANA21453.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="2"></count><count type="referenceTotal" number="107"></count><count type="wordTotal" number="7411"></count></countGroup><titleGroup><title type="main" xml:lang="en">How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?<link href="#fn1"></link></title><title type="short" xml:lang="en">Treating Motor Complications</title></titleGroup><creators><creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes"><personName><givenNames>Stanley</givenNames><familyName>Fahn</familyName><degrees>MD</degrees></personName><contactDetails><email>fahn@neuro.columbia.edu</email></contactDetails></creator></creators><affiliationGroup><affiliation xml:id="af1" countryCode="US" type="organization"><unparsedAffiliation>Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p>The motor complications associated with levodopa therapy, namely, fluctuations in motor response and dyskinesias, occur in the majority of Parkinson's disease patients. These complications can impair a patient's quality of life and even cause pronounced disability. “Off” states that result in freezing of gait and falling are disabling for many patients. Dyskinesias most commonly occur at peak dose and typically alternate with the wearing‐off state. Once these problems appear, they usually persist, and the physician needs to make continual adjustments in medications to minimize these problems. Medical treatments should be attempted before treatments such as deep brain stimulation are considered because of the potential adverse effects that are associated with surgery. The timing of surgery, however, is also important because younger patients and less advanced patients tend to have a better outcome. There is thus a need for experienced and knowledgeable physicians and surgeons who are able to handle these motor complications. This review discusses available medications and surgical approaches, and their outcomes. Ann Neurol 2008;64 (suppl):S56–S64</p></abstract></abstractGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Potential conflicts of interest: This article is part of a supplement sponsored by Boehringer Ingelheim (BI). Within the past 12 months, S.F. has received consulting fees from BI, Anteres Pharm, Eisai, EMD Serono, IMPAX Pharma, Intec Pharma, Novartis, and Teva Pharmaceuticals. S.F. received an honorarium from Merz Pharma as a member of a safety monitoring committee.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Treating Motor Complications</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?</title></titleInfo><name type="personal"><namePart type="given">Stanley</namePart><namePart type="family">Fahn</namePart><namePart type="termsOfAddress">MD</namePart><affiliation>Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY</affiliation><description>Correspondence: Neurological Institute, 710 West 168th Street, New York, NY 10032</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><place><placeTerm type="text">Hoboken</placeTerm></place><dateIssued encoding="w3cdtf">2008-12</dateIssued><dateCaptured encoding="w3cdtf">2008-04-07</dateCaptured><dateValid encoding="w3cdtf">2008-06-02</dateValid><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="figures">2</extent><extent unit="tables">2</extent><extent unit="references">107</extent><extent unit="words">7411</extent></physicalDescription><abstract lang="en">The motor complications associated with levodopa therapy, namely, fluctuations in motor response and dyskinesias, occur in the majority of Parkinson's disease patients. These complications can impair a patient's quality of life and even cause pronounced disability. “Off” states that result in freezing of gait and falling are disabling for many patients. Dyskinesias most commonly occur at peak dose and typically alternate with the wearing‐off state. Once these problems appear, they usually persist, and the physician needs to make continual adjustments in medications to minimize these problems. Medical treatments should be attempted before treatments such as deep brain stimulation are considered because of the potential adverse effects that are associated with surgery. The timing of surgery, however, is also important because younger patients and less advanced patients tend to have a better outcome. There is thus a need for experienced and knowledgeable physicians and surgeons who are able to handle these motor complications. This review discusses available medications and surgical approaches, and their outcomes. Ann Neurol 2008;64 (suppl):S56–S64</abstract><note type="content">*Potential conflicts of interest: This article is part of a supplement sponsored by Boehringer Ingelheim (BI). Within the past 12 months, S.F. has received consulting fees from BI, Anteres Pharm, Eisai, EMD Serono, IMPAX Pharma, Intec Pharma, Novartis, and Teva Pharmaceuticals. S.F. received an honorarium from Merz Pharma as a member of a safety monitoring committee.</note><relatedItem type="host"><titleInfo><title>Annals of Neurology</title><subTitle>Official Journal of the American Neurological Association and the Child Neurology Society</subTitle></titleInfo><titleInfo type="abbreviated"><title>Ann Neurol.</title></titleInfo><genre type="Journal">journal</genre><subject><genre>article category</genre><topic>Clinical Issues</topic></subject><identifier type="ISSN">0364-5134</identifier><identifier type="eISSN">1531-8249</identifier><identifier type="DOI">10.1002/(ISSN)1531-8249</identifier><identifier type="PublisherID">ANA</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>64</number></detail><detail type="issue"><caption>no.</caption><number>S2</number></detail><detail type="supplement"><caption>Suppl. no.</caption><number>2</number></detail><extent unit="pages"><start>S56</start><end>S64</end><total>9</total></extent></part></relatedItem><identifier type="istex">843236E84B9407C8CE3C3A556D642BEADB5DD433</identifier><identifier type="DOI">10.1002/ana.21453</identifier><identifier type="ArticleID">ANA21453</identifier><accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 American Neurological Association</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000126 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000126 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:843236E84B9407C8CE3C3A556D642BEADB5DD433
|texte= How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?
}}
| This area was generated with Dilib version V0.6.23. |  |